Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Martek Reaches Beyond Infant Formula To Grab Perinatal, Food Markets

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences is supplying DHA for Mission Pharmacal's upcoming Rx perinatal dietary supplement Citracal + DHA, the firm announced during a presentation to investors
Advertisement

Related Content

Martek DHA Gets Consumer-Friendly For Upcoming Functional Food Launches
Martek DHA Gets Consumer-Friendly For Upcoming Functional Food Launches
Martek DHA Gets Consumer-Friendly For Upcoming Functional Food Launches
Martek partners with Hain
Martek partners with Hain
High Omega-3 Intake Protective Against Age-Related Macular Degeneration
Martek DHA powder
Science-Based Ingredient Firms Spur Bullish Investors In Supplement Sector
LIPIL for Moms
Martek Stock To Raise $11 Mil. For Plant Upgrades; Firm Files Patent Suit

Topics

Advertisement
UsernamePublicRestriction

Register

PS099007

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel